近日,吉大一院Ⅰ期药物临床试验病房在国际顶级医学期刊《柳叶刀-感染病学杂志》(The Lancet Infectious Diseases)上发表了题为《Safety, Pharmacokinetics and Efficacy of Rifasutenizol, a Novel Dual-targeted Antibacterial Agent, in Randomized Clinical Trials in Healthy Participants and Patientswith Helicobacter pyl...